Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
MARINUS PHARMACEUTICALS INC
About MRNS
Marinus Pharmaceuticals, Inc. is a commercial-stage pharmaceutical company. The Company is engaged in the development of innovative therapeutics for the treatment of seizure disorders, including rare genetic epilepsies and status epilepticus, which includes the use of ZTALMY (ganaxolone). Its U.S. Food and Drug Administration (FDA) approved the Company’s new drug application for the use of ZTALMY oral suspension CV for the treatment of seizures associated with Cyclin-dependent Kinase-like 5 (CDKL5) Deficiency Disorder (CDD) in patients two years of age and older. The Company is also developing ganaxolone for the treatment of other rare genetic epilepsies, including Tuberous Sclerosis Complex (TSC) and for the treatment of Refractory Status Epilepticus (RSE). It is developing ganaxolone in formulations for two different routes of administration: intravenous (IV) and oral to maximize therapeutic reach for adult and pediatric patients in acute and chronic care settings.
Find out what a historical investment in MARINUS PHARMACEUTICALS INC would be worth today using our MRNS stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy MRNS shares in Australia?
Buying MRNS shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in MARINUS PHARMACEUTICALS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MRNS
What is the ticker symbol of MARINUS PHARMACEUTICALS INC?
The ticker symbol for MARINUS PHARMACEUTICALS INC is MRNS.
How much is one share of MRNS?
One share of MRNS is valued at $0.55 as of 10 June 2026.
What is the market capitalisation of MARINUS PHARMACEUTICALS INC MRNS?
As of 10 June 2026 MARINUS PHARMACEUTICALS INC has a market cap of -.
What is the 52-week high for MARINUS PHARMACEUTICALS INC stock?
The MARINUS PHARMACEUTICALS INC 52-week high stock price is $NaN.
What is the 52-week low for MARINUS PHARMACEUTICALS INC stock?
The MARINUS PHARMACEUTICALS INC 52-week low stock price is $NaN.
Can I buy MRNS shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MRNS shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MRNS on Stake
- Buy MRNS from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MRNS from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MRNS related stocks